| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |